Prosecution Insights
Last updated: November 06, 2026

Lyndsey Marie Beckhardt, USPTO Patent Examiner

Listed by the USPTO as BECKHARDT, LYNDSEY MARIE

Tech Center 3700 • Art Units: 1613 1615 1621 1674 3783

This examiner grants 28% of resolved cases

Performance Statistics

27.7%
Allow Rate
-42.3% vs TC avg
664
Total Applications
+48.0%
Interview Lift
1455
Avg Prosecution Days
Based on 573 resolved cases, 2023–2026

Rejection Statute Breakdown

0.4%
§101 Eligibility
9.8%
§102 Novelty
47.6%
§103 Obviousness
23.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17904553 CROSSLINKED POLY(LACTIDE-CO-GLYCOLIDE) (PLGA)-DIMETHACRYLATE COATINGS AND METHODS OF USE Final Rejection THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
18199939 DELIVERY DEVICES AND METHODS FOR MAKING THE SAME Final Rejection THE REGENTS OF THE UNIVERSITY OF MICHIGAN
18099810 DELIVERY DEVICES AND METHODS FOR MAKING THE SAME Final Rejection THE REGENTS OF THE UNIVERSITY OF MICHIGAN
19242592 INJECTABLE BIOPOLYMER COMPOSITIONS AND ASSOCIATED SYSTEMS AND METHODS Final Rejection Covidien LP
18327140 POWDER FOR ACHIEVING HEMOSTASIS Final Rejection Boston Scientific Scimed, Inc.
17906433 IMPLANTABLE CELL CHAMBER DEVICE AND USES THEREOF Final Rejection Takeda Pharmaceutical Company Limited
18727765 SKIN MICROBIOME FRIENDLY SUNSCREENS Non-Final OA BASF SE
17914134 METHODS FOR TISSUE REGENERATION AND KITS THEREFOR Final Rejection THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
18906741 Hair Treatment Compositions Having Anti-Dandruff Action Final Rejection Henkel AG & Co. KGaA
17785880 TINTING CONDITIONER HAVING IMPROVED DYEING PERFORMANCE Final Rejection Henkel AG & Co. KGaA
18157371 ANTI-FOULING IMPLANTABLE MATERIAL AND METHOD OF MAKING Non-Final OA Edwards Lifesciences Corporation
18017583 COMPOSITION FOR PREVENTING ADHESION Non-Final OA The University of Tokyo
18683932 STABLE CYCLOSPORINE OPHTHALMIC FORMULATION AND MANUFACTURING PROCESS THEREOF Final Rejection SUN PHARMACEUTICAL INDUSTRIES LIMITED
18177659 SILK FIBROIN COMPOSITE MATERIAL WITH INCREASED CONTENT OF BETA-SHEET AND METHOD FOR PREPARING THE SAME Non-Final OA Industry-Academic Cooperation Foundation, Yonsei University
18634454 FORMATION OF STABLE SUBMICRON PEPTIDE OR PROTEIN PARTICLES BY THIN FILM FREEZING Non-Final OA BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
17916215 NANOFIBER-ENABLED ENCAPSULATION DEVICES AND USES THEREOF Final Rejection CORNELL UNIVERSITY
18577168 COMPOSITIONS, METHODS AND SYSTEMS FOR AEROSOL DRUG DELIVERY Non-Final OA ASTRAZENECA PHARMACEUTICALS LP
18722151 COSMETIC COMPOSITION COMPRISING A NATURAL RESIN Non-Final OA L'OREAL
18716673 COMPOSITION COMPRISING A POLYHYDROXYALKANOATE COPOLYMER WITH A LONG HYDROCARBON-BASED CHAIN BEARING IONIC GROUP(S), AND METHOD FOR TREATING KERATIN MATERIALS USING THE COMPOSITION Non-Final OA L'Oreal
18704717 COMPOSITION COMPRISING A PARTICULAR OXIDATION DYE PRECURSOR AND TWO PARTICULAR ACIDS Non-Final OA L'OREAL
18044233 PHARMACEUTICAL COMPOSITION COMPRISING CHLOROQUINE AND USES THEREOF Non-Final OA Philip Morris Products S.A.
18727872 Antibacterial Resin and Molded Body Comprising Same Final Rejection LG Chem, Ltd.
18590499 COSMETIC AEROSOL PRODUCT Non-Final OA Conopco, Inc., d/b/a UNILEVER
17774409 ADHESIVE COMPOSITIONS COMPRISING THERAPEUTICS Non-Final OA RevBio, Inc.
18246449 DRUG COATING, DRUG-COATED BALLOON AND PREPARATION METHOD THEREOF Final Rejection LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
18839511 KIT OF COSMETIC COMPOSITIONS Non-Final OA THE BOOTS COMPANY PLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Lyndsey Marie Beckhardt's allowance rate?

27.7% of resolved applications examined by Lyndsey Marie Beckhardt were allowed (573 resolved cases), compared with 33.8% across Art Unit 1613 over the last five years.

Does an interview help with examiner Lyndsey Marie Beckhardt?

This examiner's interview lift is +48.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Lyndsey Marie Beckhardt take to allow a patent?

Applications allowed by Lyndsey Marie Beckhardt took 1,455 days on average from filing to allowance.

Which art unit does examiner Lyndsey Marie Beckhardt work in?

Lyndsey Marie Beckhardt examines applications in Art Unit 1613 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month